An open-label, community-based, 12-week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads).

Cutis; cutaneous medicine for the practitioner

Volumn 86, Issue 5 Suppl, 2010, Pages 7-15

  Webster, Guy F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE;

ARTICLE; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHASE 4 CLINICAL TRIAL; ROSACEA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; DELAYED-ACTION PREPARATIONS; DOXYCYCLINE; FEMALE; HUMANS; MALE; MIDDLE AGED; ROSACEA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79952275470     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)